Global Immuno-Oncology Market to Experience 21% CAGR Backed by Personalized Medicine by 2030
The global immuno-oncology market is set to witness a growth rate of 21% in the next 5 years. Increasing incidence and prevalence of cancer, advancements in immunotherapy and personalized medicine, favorable regulatory support and approvals, growing investment in cancer immunotherapy R&D, and expanding applications beyond traditional indications are some of the key factors driving the […]
Continue Reading